Objectives Spironolactone,an aldosterone receptor blocker,has been shown to be beneficial in patients with chronic severe heart failure.We tested whether low do
Background In patients with heart failure(HF),beta-blockers reduce mortality.This meta-analysis aimed at clarifying the true beneficial effects of the 3 beta-bl